Asthma IQ for Primary Care Physicians
Study Description and Methods
This study will examine whether the use of the ASTHMA IQ primary care tool will improve asthma care and asthma outcomes using a randomized trial of the ASTHMA IQ system versus usual asthma care in the primary care setting.
Practices will be randomized into two groups of two to four, or sufficient to achieve 20 physicians in each group with an average of 10 patients per physician. The Asthma IQ group 1 will be trained to use the software and how the system can support both acute and planned patient visits in their office. We will also support practices in the design of planned care visits. The Asthma IQ group 2 will be trained on the new asthma guidelines and how a structured approach to planned care can help deliver guideline concordant care. We will also provide support for design of planned visits for this group. We will survey office staff and clinicians in both groups on their current practice and approach to asthma care at baseline, 6 months, 12 months, 18 months, and 24 months. Patient chart reviews will also be done by study personnel and complemented by automated surveys of patients regarding asthma control and urgent care visits at baseline and every three months, using the ACT tool and specific questionnaires. After 12 months, Asthma IQ group 2 will be trained on the use of the Asthma IQ software.
Specific Aims and Objectives
- To determine if the use of the Asthma IQ tool will improve asthma patient outcomes as assessed by quarterly assessments of ACT scores via automated patient survey (primary endpoint).
- To determine if the use of the Asthma IQ tool will improve asthma patient outcomes as assessed by the number of asthma exacerbations requiring the use of systemic corticosteroids for three or more days (secondary endpoint).
This project will be conducted between December 2010 and November 2013.
This project is wrapping up data collection. Check back soon for preliminary findings.
For additional information about this study, please contact:
Laura Nichols, MS
AAFP National Research Network/University of Colorado
AAFP National Research Network
This project was funded by an unrestricted grant from Novartis.